These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 12352915)

  • 21. Flow cytometry PRA using lymphocyte pools from random donors.
    Won DI; Jung HD; Jung OJ; Huh S; Suh JS
    Cytometry B Clin Cytom; 2007 Jul; 72(4):256-64. PubMed ID: 17205570
    [TBL] [Abstract][Full Text] [Related]  

  • 22. De novo produced anti-human leukocyte antigen antibodies relation to alloimmunity in patients with chronic renal failure.
    Pirim I; Soyoz M; Ayna TK; Kocyigit AO; Gurbuz BC; Tugmen C; Kurtulmus Y; Ozyilmaz B
    Genet Test Mol Biomarkers; 2015 Jun; 19(6):335-8. PubMed ID: 25826018
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevalence and specificity of immunoglobulin G and immunoglobulin A non-complement-binding anti-HLA alloantibodies in retransplant candidates.
    Arnold ML; Dechant M; Doxiadis II; Spriewald BM
    Tissue Antigens; 2008 Jul; 72(1):60-6. PubMed ID: 18588575
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Flow cytometry beads rather than the antihuman globulin method should be used to detect HLA Class I IgG antibody (PRA) in cadaveric renal regraft candidates.
    Bryan CF; McDonald SB; Baier KA; Luger AM; Aeder MI; Murillo D; Muruve NA; Nelson PW; Shield CF; Warady BA
    Clin Transplant; 2002; 16 Suppl 7():15-23. PubMed ID: 12372039
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of different sensitization events on HLA alloimmunization in solid organ transplantation patients.
    Hyun J; Park KD; Yoo Y; Lee B; Han BY; Song EY; Park MH
    Transplant Proc; 2012 Jan; 44(1):222-5. PubMed ID: 22310619
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Detection of HLA class I- and class II-specific antibodies by flow cytometry and PRA-STAT screening in renal transplant recipients.
    Harmer AW; Heads AJ; Vaughn RW
    Transplantation; 1997 Jun; 63(12):1828-32. PubMed ID: 9210512
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Correlation of ELISA-detected IgG and IgA anti-HLA antibodies in pretransplant sera with renal allograft rejection.
    Kerman RH; Susskind B; Buelow R; Regan J; Pouletty P; Williams J; Gerolami K; Kerman DH; Katz SM; Van Buren CT; Kahan BD
    Transplantation; 1996 Jul; 62(2):201-5. PubMed ID: 8755816
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sensitivity, specificity and clinical relevance of different cross-matching assays in deceased-donor renal transplantation.
    Ho EK; Vasilescu ER; Colovai AI; Stokes MB; Hallar M; Markowitz GS; D'Agati VD; Cohen DJ; Ratner LE; Suciu-Foca N
    Transpl Immunol; 2008 Nov; 20(1-2):61-7. PubMed ID: 18929659
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reappraisal of HLA antibody analysis and crossmatching in kidney transplantation.
    Lee PC; Ozawa M
    Clin Transpl; 2007; ():219-26. PubMed ID: 18642453
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Aortic valve allograft structural deterioration is associated with a subset of antibodies to human leukocyte antigens.
    Dignan R; O'Brien M; Hogan P; Thornton A; Fowler K; Byrne D; Stephens F; Harrocks S
    J Heart Valve Dis; 2003 May; 12(3):382-90; discussion 390-1. PubMed ID: 12803340
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Alloantibodies and the outcome of cadaver kidney allografts.
    Vasilescu ER; Ho EK; Colovai AI; Vlad G; Foca-Rodi A; Markowitz GS; D'Agati V; Hardy MA; Ratner LE; Suciu-Foca N
    Hum Immunol; 2006 Aug; 67(8):597-604. PubMed ID: 16916655
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Extra reactivities detected in flow-cytometry-positive, CDC-negative crossmatches are definable HLA specificities.
    Rodey G; Bollig B; Oldfather J; Schutte L; Flye W; Phelan D
    Transplant Proc; 1987 Feb; 19(1 Pt 1):778-9. PubMed ID: 3274872
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Detection and analysis of HLA class I and class II specific alloantibodies in the sera of dialysis recipients waiting for a renal retransplantation.
    Barocci S; Valente U; Nocera A
    Clin Transplant; 2007; 21(1):47-56. PubMed ID: 17302591
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Algorithm to manage highly sensitized kidney transplant recipients in Poland.
    Zielińska H; Moszkowska G; Zieliński M; Debska-Ślizień A; Rutkowski B; Trzonkowski P
    Transplant Proc; 2011 Oct; 43(8):2903-7. PubMed ID: 21996185
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Flow cytometric detection of complement-activating HLA antibodies.
    Schönemann C; Lachmann N; Kiesewetter H; Salama A
    Cytometry B Clin Cytom; 2004 Nov; 62(1):39-45. PubMed ID: 15476206
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A rapid flow cytometry assay for HLA antibody detection using a pooled cell panel covering 14 serological crossreacting groups.
    Shroyer TW; Deierhoi MH; Mink CA; Cagle LR; Hudson SL; Rhea SD; Diethelm AG
    Transplantation; 1995 Feb; 59(4):626-30. PubMed ID: 7878769
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Flow cytometric platelet cross-matching to predict platelet transfusion in acute leukemia.
    Sayed D; Bakry R; El-Sharkawy N; Zahran A; Khalaf MR
    J Clin Apher; 2011; 26(1):23-8. PubMed ID: 21312256
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of the established standard complement-dependent cytotoxicity and flow cytometric crossmatch assays with a novel ELISA-based HLA crossmatch procedure.
    Altermann WW; Seliger B; Sel S; Wendt D; Schlaf G
    Histol Histopathol; 2006 Oct; 21(10):1115-24. PubMed ID: 16835834
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Comparative evaluation of ELISA and Luminex panel reactive antibody assays for HLA alloantibody screening].
    Jung S; Oh EJ; Yang CW; Ahn WS; Kim Y; Park YJ; Han K
    Korean J Lab Med; 2009 Oct; 29(5):473-80. PubMed ID: 19893358
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Detection of HLA class I and II antibodies by ELISA and complement-dependent cytotoxicity before and after transplantation.
    Christiaans MH; Nieman F; van Hooff JP; van den Berg-Loonen EM
    Transplantation; 2000 Mar; 69(5):917-27. PubMed ID: 10755551
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.